Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines

[1]  P. Steeg,et al.  Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. , 1996, Cancer research.

[2]  M. Grever,et al.  Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. , 1996, Journal of the National Cancer Institute.

[3]  S. Al-Sedairy,et al.  Effects of cytokine‐mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells , 2006, International journal of cancer.

[4]  M R Grever,et al.  In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.

[5]  M. Grever,et al.  Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. , 1995, The Journal of clinical investigation.

[6]  H. Tanaka,et al.  Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. , 1995, Cancer research.

[7]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[8]  Roger L. Williams,et al.  Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  M J Bissell,et al.  A Novel Function for the nm23-Hl Gene: Overexpression in Human Breast Carcinoma Cells Leads to the Formation of Basement Membrane and Growth Arrest , 2010 .

[10]  D. Lednicer,et al.  Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. , 1994, Journal of medicinal chemistry.

[11]  S. Hecht,et al.  Inhibition of topoisomerase I function by nitidine and fagaronine. , 1993, Chemical research in toxicology.

[12]  P. Steeg,et al.  Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. , 1993, Oncogene.

[13]  D. Elder,et al.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. , 1993, The American journal of pathology.

[14]  P. Steeg,et al.  Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.

[15]  K D Paull,et al.  Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. , 1992, Cancer research.

[16]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[17]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[18]  R. Kerbel,et al.  Reduction of TGF‐beta activity abrogates growth promoting tumor cell‐cell interactions in vivo , 1991, Journal of cellular physiology.

[19]  K D Paull,et al.  Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. , 1991, The Journal of biological chemistry.

[20]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[21]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[22]  J M Pezzuto,et al.  Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. , 1991, Journal of natural products.

[23]  S. Winawer,et al.  Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  D. Iliopoulos,et al.  In vitro properties of human melanoma cells metastatic in nude mice. , 1990, Cancer research.

[25]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[26]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[27]  D A Scudiero,et al.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.

[28]  W. Clark,et al.  Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. , 1989, Journal of the National Cancer Institute.

[29]  M. Gingras,et al.  Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. , 1988, Cancer research.

[30]  E. Kohn,et al.  Insulin-like growth factors stimulate chemotaxis in human melanoma cells. , 1988, Biochemical and biophysical research communications.

[31]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[32]  P. Kovacic,et al.  Charge transfer-oxy radical mechanism for anti-cancer agents. , 1986, Anti-cancer drug design.

[33]  M. L. Sethi.  Inhibition of reverse transcriptase activity by benzophenanthridine alkaloids. , 1979, Journal of natural products.

[34]  R. K. Zee-Cheng,et al.  Inhibition of catechol O-methyltransferase and transfer RNA methyltransferases by coralyne, nitidine, and related compounds. , 1977, Journal of pharmaceutical sciences.

[35]  V. Sethi.  Inhibition of mammalian and oncornavirus nucleic acid polymerase activities by alkoxybenzophenanthridine alkaloids. , 1976, Cancer research.

[36]  F. Stermitz,et al.  Synthesis and biological activity of some antitumor benzophenanthridinium salts. , 1975, Journal of medicinal chemistry.